)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Sharps Technology
Sharps Technology (STSS) investor relations material
Sharps Technology Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary31 Mar, 2026
Executive summary
Transitioned from syringe manufacturing to a dual focus on medical device distribution and a digital asset treasury strategy centered on Solana (SOL), with over 2 million SOL held as of year-end 2025.
Discontinued R&D and manufacturing, spun off Hungarian subsidiary, and settled related litigation.
Initiated a $100M share repurchase program and completed significant equity and digital asset financings, raising over $400M in August 2025.
Financial highlights
Reported net loss of $282.5M for 2025, driven by $152.9M unrealized losses on SOL, $101.3M warrant issuance expense, and $107.5M in stock-based compensation.
Revenues: $204K from medical device sales and $6.8M net staking revenue from SOL.
Cash at year-end: $10.4M; digital assets at fair value: $250.1M; working capital: $14.2M.
Gross proceeds from August 2025 PIPE and related offerings: $411M; net proceeds: $403M.
Outlook and guidance
Focus on expanding medical device distribution and leveraging SOL treasury for long-term growth and potential acquisitions.
Plans to maintain high SOL exposure, generate yield through staking, and selectively use derivatives for risk management.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sharps Technology
- First revenues, $50M U.S. deal, and expansion into high-margin prefilled syringes drive growth.STSS
Life Sciences Virtual Investor Forum29 Dec 2025 - Stockholders considered a reverse split, warrant issuance, and adjournment, with quorum met.STSSStatus Update24 Dec 2025
- Hybrid medical device and SOL treasury strategy, with major warrant-driven capital raise.STSSRegistration Filing23 Dec 2025
- Dual medical device and SOL treasury strategy with $1B shelf, high risk and regulatory exposure.STSSRegistration Filing23 Dec 2025
- Expanding syringe production and global reach, with new supply deals and Nasdaq compliance actions.STSSRegistration Filing16 Dec 2025
- Safety syringe innovator secures major supply deal and maintains Nasdaq listing amid legal risks.STSSRegistration Filing16 Dec 2025
- Patented syringe maker secures $50M+ supply deal; 259,092 shares registered for resale.STSSRegistration Filing16 Dec 2025
- Dual focus on medical devices and a SOL-centric treasury strategy drives high risk and flexibility.STSSRegistration Filing16 Dec 2025
- IPO registers resale of shares and warrants, highlighting a strategic pivot to SOL-focused treasury.STSSRegistration Filing16 Dec 2025
Sharps Technology
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage